77
Participants
Start Date
March 1, 2018
Primary Completion Date
September 8, 2023
Study Completion Date
September 8, 2023
solifenacin
Antimuscarinic bladder relaxant, antagonizes bladder muscarinic receptors
Pelvic floor muscle exercise-based behavioral therapy
Multicomponent intervention including fluid management, constipation management and behavioral techniques incorporating pelvic floor muscle-exercise based urge suppression and self-monitoring to reduce overactive bladder symptoms
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Birmingham VA Medical Center, Birmingham, AL, Birmingham
Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
VA Office of Research and Development
FED